Ainos, Inc. (NASDAQ:AIMD) Short Interest Down 35.1% in August

Ainos, Inc. (NASDAQ:AIMD) was the recipient of a significant drop in short interest in August. As of August 31st, there was short interest totalling 53,300 shares, a drop of 35.1% from the August 15th total of 82,100 shares. Based on an average daily volume of 245,400 shares, the days-to-cover ratio is currently 0.2 days. Approximately 0.9% of the company’s shares are sold short.

Ainos Price Performance

Shares of AIMD stock opened at $0.61 on Friday. Ainos has a 12 month low of $0.55 and a 12 month high of $2.35. The stock has a market cap of $12.42 million, a PE ratio of -0.70 and a beta of 1.09. The company has a current ratio of 1.92, a quick ratio of 1.45 and a debt-to-equity ratio of 0.08.

Ainos Company Profile

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.